
Journal of Organic Chemistry p. 8723 - 8731 (2020)
Update date:2022-08-03
Topics:
Li, Junlan
Liu, Lihua
Zheng, Kaiting
Zheng, Chenggong
Xiao, Hua
Fan, Shilu
The incorporation of a perfluoroalkyl group (RF) into drug candidates has become an increasingly important strategy in drug molecule design. In this study, the silver-mediated perfluoroalkylation reaction based on the addition-elimination process of terminal alkynes which was initiated by a perfluoroalkyl radical to form a C(sp)-RF bond has been developed. The reaction proceeds under mild conditions using readily available, low-cost perfluoroalkyl iodides as the sources of the RF group. This method allows access to a variety of perfluoroalkylated alkynes.
QINGDAO ON-BILLION INDUSTRAIL CO.,LTD
website:http://www.obn.com.cn
Contact:+86-15005320811 +86-532-80681989
Address:F35 Parkson Mansion No.44-60 Zhongshan Rd.
zhengzhou Triz Pharma-Tech Co., Ltd
website:http://www.Trizpharma-tech.com
Contact:+86-0371-86597269,53392065
Address:High-tech Industrial Development Zone, Zhengzhou City, NO.7 Holly Street
Feis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Chengdu D-Innovation Pharmaceutical Co., Ltd
Contact:86-28-85105536
Address:1001, B6, No.88 Keyuan South Road, Chengdu Hi-Tech Zone
Lianyungang Ningkang Chemical Co., Ltd
Contact:.+86-518-88588008
Address:http://www.chemnk.com
Doi:10.1139/v74-205
(1974)Doi:10.1021/jo00938a010
(1974)Doi:10.1021/ja00339a017
(1983)Doi:10.1002/ejic.200390019
(2003)Doi:10.1021/jo00256a014
(1988)Doi:10.1021/ja00008a058
(1991)